Sarepta Therapeutics (SRPT) says siRNA achieves high muscle concentrations without dose limiting toxicity for FSHD1 and DM1
Every headline is on the live feed 20 minutes before this site.
Hapag Lloyd (HLAG GY) CEO expects high additional costs of USD 40-50mln a week due to the blockade of the Strait of Hormuz, via RTL/NTV Interview
Barclays (BARC LN) reportedly pulls back on asset-based lending after MFS and Tricolor, Bloomberg reports; Shifting its focus to loans and securitizations for larger corporates
Sarepta Therapeutics (SRPT) says siRNA achieves high muscle concentrations without dose limiting toxicity for FSHD1 and DM1
Russia may reinstate temporary ban on gasoline exports, IFX reports
SLB (SLB) to serve as modular design partner for Nvidia (NVDA) DSX AI Factories; SLB and NVDA will develop an AI factory for Energy with Generative AI models
On the Newsquawk feed at , 20 minutes before this page.
Context
Sarepta Therapeutics reported promising results for their siRNA treatment, indicating significant muscle concentrations without dose-limiting toxicity for FSHD1 and DM1. This outcome not only bodes well for their pipeline but may also lead to increased investor confidence and potential upward adjustments in stock price, impacting the broader biotech sector.
Related headlines
- Weekly US Earnings Estimates: 19th-23rd October 2026: Earnings pick up with META, TSLA, SPCX, LRCX, and NFLX the highlights14 hours ago
- Nvidia (NVDA) expands tools for building AI-powered games with Unreal Engine 515 hours ago
- US FAA is set to approve certification for the Boeing (BA) 737 MAX 10, sources report; potentially as soon as in the next week16 hours ago
- Daily US Earnings Estimates: 19th October 2026: FITB, WRB, and STLD17 hours ago
- T-Mobile (TMUS) downside attributed to a terminated relationship with SpaceX (SPCX) - UNCONFIRMED18 hours ago
- Michael Dell (DELL) expects memory crunch to get worse, WSJ reports18 hours ago
- US officials pressed Beijing on market access issues for Mastercard (MA) and Citigroup (C) during at least two bilateral meetings with Chinese counterparts in Bangkok this week, CNBC reports, citing a source18 hours ago
- Apple (AAPL) set for UK legal fight over iPhone tap-to-pay rules, FT reports19 hours ago
- US EQUITY OPEN: Stocks mixed at the open as AI stock rout continues20 hours ago
- US DoJ officials have reportedly signalled their preference to settle antitrust lawsuit against Apple (AAPL), The Information reports citing sources21 hours ago
- Daily US Equity Opening News: 16th October 2026: TSLA gains on Roadster reveal; NFLX slips as Content Chief to leave; TRV earnings underwhelm21 hours ago
- US PREMARKET MOVERS: TSLA, NFLX, VRNS, AA, TRV, MSTR, WDAY, ECHO21 hours ago
- Charles Schwab (SCHW) CEO says seeing record levels of interest in fixed income; Brokerage is blocking unauthorised AI agents21 hours ago
- Apple (AAPL) iPhone duo delivery date slips to January 25th22 hours ago
- US BROKER MOVES: CPRI upgrade at Raymond James; WDAY downgraded at KeyBanc22 hours ago
- Apple's (AAPL) iPhone Duo sells out minutes after pre-orders open, according to Apple Insider22 hours ago
- ExxonMobil (XOM) says changes in margins to impact Q3 chemical products earnings by USD -0.6bln Q/Q22 hours ago
- Marqeta (MQ) and Coinbase (COIN) to enable stablecoin-backed card payments22 hours ago
- Nvidia's (NVDA) RTX Spark laptops have launched globally, starting at USD 2,59922 hours ago
- Travelers (TRV) Q3 2026 (USD): Adj. EPS 9.18 (exp. 7.39), Revenue 12.4bln (exp. 11.4bln); Net Premiums Written 11.48bln (exp. 11.40bln), Catastrophe Loss 538mln (exp. 695mln)23 hours ago
The feed had this first.
Use the Platform